GSK1070916A

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK1070916A, covering 2013-05-01 to 2013-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors [Phase 1]